Laboratory ultracentrifuge AW Promatix 1000™

for the pharmaceutical industryon castersautomatic

AW Promatix 1000™ Research and Development with Linear Scalability The AW Promatix 1000™ is designed to develop protocols for the separation, fractionation and concentration of viral vectors, virus-like particles, viruses, viral and bacterial vaccines, macromolecules and cellular organelles Fully programmable to run user defined applications. Fully automated for gradient and product loading, continuous fl ow separation, fraction collection and cleaning. The system provides operators with easy to read continuous displays of operational steps, critical run data and subsystem status. Scalable cores available with the Promatix 1000 enable researchers to utilize continuous flow methodologies with research scale process volumes and eliminate traditional small scale, batch-type processes. The AWST patented core technology allows for linear scalability to full manufacturing scale with no revalidation or compromise of yield and purity. Process volumes from 500 mL to 10 Electric motor drive Linear scale down or scale up capability Rotor capacities:55 mL, 120 mL, 230 m Speed:35,000 rpm Centrifugal force:90,500 xg Efficiently capture AAV vectors of any serotype Alfa Wassermann’s continuous flow ultracentrifuge efficiently captures AAV vectors of any serotype. Significantly improved recovery level – up to 50% Achieves expanded yields with continuous flow loading. Dramatically reduce turn around times over conventional column purification. Successful Adeno associated virus (AAV) vector purification has been achieved in large quantities using the Alfa Wassermann AW Promatix 1000™ continuous flow ultracentrifuge*.